Thomas Β Cooper,
#134,340
Most Influential Person Now
Thomas Β Cooper,'s AcademicInfluence.com Rankings
Thomas Β Cooper,biology Degrees
Biology
#9086
World Rank
#12245
Historical Rank
Neuroscience
#1305
World Rank
#1350
Historical Rank

Download Badge
Biology
Thomas Β Cooper,'s Degrees
- Doctorate Psychiatry Stanford University
Why Is Thomas Β Cooper, Influential?
(Suggest an Edit or Addition)Thomas Β Cooper,'s Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. (1989) (1116)
- Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. (2000) (1039)
- Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. (2001) (635)
- Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction (2005) (563)
- Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. (2002) (525)
- Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. (2003) (483)
- Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. (1998) (469)
- Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial. (1988) (461)
- Circadian time of morning light administration and therapeutic response in winter depression. (2001) (347)
- Cerebrospinal fluid vasopressin levels: correlates with aggression and serotonin function in personality-disordered subjects. (1998) (331)
- Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression. (2003) (321)
- Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. (1996) (319)
- Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function. (2005) (307)
- Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder. (2006) (301)
- Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. (1992) (263)
- Dopamine blockade and clinical response: evidence for two biological subgroups of schizophrenia. (1989) (261)
- Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders. (2003) (251)
- Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. (2002) (237)
- β-Endorphin-Induced Changes in Schizophrenic and Depressed Patients (1977) (230)
- Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects. (2009) (224)
- A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease. (1998) (215)
- Upregulation of CB1 receptors and agonist-stimulated [35S]GTPγS binding in the prefrontal cortex of depressed suicide victims (2004) (204)
- Clozapine, Olanzapine, Risperidone, and Haloperidol in the Treatment of Patients With Chronic Schizophrenia and Schizoaffective Disorder (2002) (192)
- Central serotonin activity and aggression: inverse relationship with prolactin response to d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects. (1997) (191)
- Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. (1996) (191)
- Relationship between age and tricyclic antidepressant plasma levels. (1977) (189)
- Human brain fluoxetine concentrations. (1993) (187)
- Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers (1993) (177)
- Overt Aggression and Psychotic Symptoms in Patients With Schizophrenia Treated With Clozapine, Olanzapine, Risperidone, or Haloperidol (2004) (176)
- Antipsychotic-Induced Weight Gain and Therapeutic Response: A Differential Association (2002) (174)
- Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a "fixed plasma level" design. (1990) (155)
- Cerebrospinal fluid concentrations of somatostatin and biogenic amines in grown primates reared by mothers exposed to manipulated foraging conditions. (1998) (149)
- Low testosterone levels in elderly men with dysthymic disorder. (2002) (140)
- Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons. (2000) (139)
- A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients. (1989) (139)
- Chronic ethanol administration down-regulates cannabinoid receptors in mouse brain synaptic plasma membrane (1998) (136)
- The 24-hour serum lithium level as a prognosticator of dosage requirements. (1973) (133)
- Evaluation of lithium therapy in chronic and periodic alcoholism (1974) (133)
- Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brain (1992) (131)
- Plasma Level Monitoring of Antipsychotic Drugs (1978) (131)
- Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol. (2004) (130)
- Adjunctive imipramine in the treatment of postpsychotic depression. A controlled trial. (1987) (127)
- Lower Cortisol Levels in Depressed Patients with Comorbid Post-Traumatic Stress Disorder (2003) (127)
- Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6- to 12-year-olds with major depressive disorder. (1992) (125)
- Neuroendocrine response to fenfluramine challenge in boys. Associations with aggressive behavior and adverse rearing. (1997) (124)
- Elevated levels of endocannabinoids and CB1 receptor-mediated G-protein signaling in the prefrontal cortex of alcoholic suicide victims (2005) (120)
- Acute Occupancy of Brain Serotonin Transporter by Sertraline as Measured by [11C]DASB and Positron Emission Tomography (2006) (118)
- Imipramine in adolescent major depression: plasma level and clinical response (1986) (116)
- Serotonin function in human subjects: intercorrelations among central 5-HT indices and aggressiveness (1997) (116)
- Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons. (2003) (114)
- Ketamine versus midazolam in bipolar depression with suicidal thoughts: A pilot midazolam‐controlled randomized clinical trial (2017) (112)
- Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly (1986) (109)
- A Pilot In Vivo Proton Magnetic Resonance Spectroscopy Study of Amino Acid Neurotransmitter Response to Ketamine Treatment of Major Depressive Disorder (2015) (109)
- The use of imipramine in depressed patients with congestive heart failure. (1983) (108)
- Neuroendocrine responses to challenge with dl-fenfluramine and aggression in disruptive behavior disorders of children and adolescents (1992) (106)
- Dopamine receptor occupancy and plasma haloperidol levels. (1989) (106)
- Increased ethanol consumption and preference and decreased ethanol sensitivity in female FAAH knockout mice (2006) (105)
- Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides. (2010) (104)
- Decreased serotonin function in bulimia nervosa. (1997) (102)
- Pharmacokinetics of betamethasone in twin and singleton pregnancy (2002) (101)
- Lithium for prepubertal depressed children with family history predictors of future bipolarity: a double-blind, placebo-controlled study. (1998) (101)
- Blunted HPA Axis Activity in Suicide Attempters Compared to those at High Risk for Suicidal Behavior (2016) (97)
- Simultaneous determination of imipramine, desipramine, and their 2-hydroxy metabolites in plasma by ion-pair reversed-phase high-performance liquid chromatography with amperometric detection. (1981) (95)
- Effect of chronic ethanol exposure and its withdrawal on the endocannabinoid system (2006) (90)
- Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial (1996) (89)
- Low Cerebrospinal Fluid Transthyretin Levels in Depression: Correlations with Suicidal Ideation and Low Serotonin Function (2006) (89)
- Sex-Specific Effects of Chronic Fluoxetine Treatment on Neuroplasticity and Pharmacokinetics in Mice (2010) (86)
- Pharmacokinetics of bupropion and metabolites in plasma and brain of rats, mice, and guinea pigs. (1986) (85)
- Formation of fatty acid ethyl esters during chronic ethanol treatment in mice. (1988) (81)
- Determination of bupropion and its major basic metabolites in plasma by liquid chromatography with dual-wavelength ultraviolet detection. (1984) (80)
- Testosterone levels in suicide attempters with bipolar disorder. (2012) (77)
- Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression. (2005) (76)
- Dysfunction in Fatty Acid Amide Hydrolase Is Associated with Depressive-Like Behavior in Wistar Kyoto Rats (2012) (76)
- Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia. (2004) (76)
- Pharmacological Strategies in the Prevention of Relapse After Electroconvulsive Therapy (2013) (73)
- Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder. (1997) (73)
- Behavioral and cardiovascular effects of intravenous methylphenidate in normal subjects and cocaine abusers (1997) (71)
- Glucocorticoid level and neuropsychiatric symptoms in homosexual men with HIV infection. (1991) (71)
- Noradrenergic function in obsessive-compulsive disorder: Behavioral and neuroendocrine responses to clonidine and comparison to healthy controls (1991) (69)
- Methylphenidate Response, Psychopathology and Tardive Dyskinesia as Predictors of Relapse in Schizophrenia (1994) (66)
- Sensitive and selective liquid-chromatographic assay of fluoxetine and norfluoxetine in plasma with fluorescence detection after precolumn derivatization. (1992) (65)
- Sensitive and selective liquid chromatographic assay of memantine in plasma with fluorescence detection after pre-column derivatization. (1999) (65)
- Dexmedetomidine increases the cocaine seizure threshold in rats. (2002) (64)
- Tricyclic antidepressant and metabolite levels in chronic renal failure (1985) (62)
- DNA Methylation Perturbations in Genes Involved in Polyunsaturated Fatty Acid Biosynthesis Associated with Depression and Suicide Risk (2015) (62)
- Omega-3 polyunsaturated fatty acid (PUFA) status in major depressive disorder with comorbid anxiety disorders. (2013) (61)
- Disappearance of memory deficits in outpatient depressives responding to imipramine. (1991) (60)
- Weight Gain During a Double-Blind Multidosage Clozapine Study (2007) (59)
- Future Suicide Attempt and Responses to Serotonergic Challenge (2010) (58)
- Hormone responses to fenfluramine and placebo challenge in endogenous depression (1992) (57)
- Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder. (1997) (57)
- How effective and safe is continuation therapy in elderly depressed patients? Factors affecting relapse rate. (1988) (56)
- Further evidence of low baseline cortisol levels in suicide attempters. (2016) (55)
- Plasma haloperidol levels and clinical effects in schizophrenia and schizoaffective disorder. (1995) (53)
- The tyramine challenge test as a marker for melancholia. (1984) (53)
- Effect of chronic ethanol exposure on mouse brain arachidonic acid specific phospholipase A2. (1998) (53)
- Drug treatment of depression in frail elderly nursing home residents. (2000) (53)
- Serum Antimuscarinic Activity During Clozapine Treatment (2003) (53)
- Effects of chronic antidepressant treatment on serotonin receptor activity in mice. (1983) (53)
- Plasma clozapine concentration coefficients of variation in a long-term study (2004) (53)
- Gender-related differences in cocaine toxicity in the rat. (1993) (52)
- GLC analysis of loxapine, amoxapine, and their metabolites in serum and urine. (1979) (52)
- Pharmacokinetics of chlorimipramine and its demethylated metabolite in blood and brain regions of rats treated acutely and chronically with chlorimipramine. (1983) (52)
- Cortisol response to diazepam: its relationship to age, dose, duration of treatment, and presence of generalized anxiety disorder (2005) (52)
- Enantiomeric determination of the phenylmorpholinol metabolite of bupropion in human plasma using coupled achiral-chiral liquid chromatography. (1997) (51)
- Prediction of individual dosage of nortriptyline. (1978) (50)
- Ethanol-induced changes in the content of triglycerides, ceramides, and glucosylceramides in cultured neurons. (2005) (50)
- Does clozapine decrease smoking? (2005) (48)
- Factors affecting the delay of antidepressant effect in responders to Nortriptyline and Phenelzine (1989) (48)
- ANXIETY IN MAJOR DEPRESSION AND CEREBROSPINAL FLUID FREE GAMMA‐AMINOBUTYRIC ACID (2014) (48)
- Early findings from a pharmacokinetically designed double-blind and placebo-controlled study of lithium for adolescents comorbid with bipolar and substance dependency disorders (1992) (48)
- Effect of antiparkinsonian medication on plasma levels of chlorpromazine. (1980) (48)
- Differential effects of methylphenidate and dextroamphetamine on the motor activity level of hyperactive children. (1989) (48)
- Response of Depressive Symptoms to Nortriptyline, Phenelzine and Placebo (1987) (47)
- Effects of tryptophan depletion on the binding of [11C]-DASB to the serotonin transporter in baboons: Response to acute serotonin deficiency (2005) (46)
- Activation of arachidonic acid-specific phospholipase A2 in human neuroblastoma cells after chronic alcohol exposure: prevention by GM1 ganglioside. (1997) (46)
- WILL AMITRIPTYLINE PREVENT THE "CHEESE" REACTION OF MONOAMINE-OXIDASE INHIBITORS? (1982) (43)
- Persistence of blunted human growth hormone response to clonidine in fluoxetine-treated patients with panic disorder. (1995) (43)
- Heuristic comparison of sertraline with nortriptyline for the treatment of depression in frail elderly patients. (2000) (42)
- Dr. Douyon and Associates Reply (1989) (42)
- Omega-3 polyunsaturated fatty acid supplementation and white matter changes in major depression. (2016) (41)
- Evaluation of a slow-release lithium carbonate formulation. (1978) (41)
- Association of testosterone levels and future suicide attempts in females with bipolar disorder. (2014) (41)
- Hormonal Responses to d- and d,l-Fenfluramine in Healthy Human Subjects (1996) (41)
- Plasma tryptophan during weight restoration in patients with anorexia nervosa (2005) (40)
- Acute d-amphetamine challenge in schizophrenia: Effects on cerebral glucose utilization and clinical symptomatology (1994) (40)
- Prenatal exposure to imipramine alters early behavioral development and beta adrenergic receptors in rats. (1981) (40)
- Blunted change in cerebral glucose utilization after haloperidol treatment in schizophrenic patients with prominent negative symptoms. (1996) (39)
- Thymoleptic and neuroleptic drug plasma levels in psychiatry: current status. (1976) (38)
- High-performance liquid chromatographic method for the analysis of plasma m-chlorophenylpiperazine. (1990) (38)
- Uncoupling of the Noradrenergic-Hypothalamic-Pituitary-Adrenal Axis in Panic Disorder Patients (1995) (38)
- Serotonin Function Following Remission from Bulimia Nervosa (2000) (38)
- A Pulmonary Formulation of l-Dopa Enhances Its Effectiveness in a Rat Model of Parkinson's Disease (2004) (38)
- Metabolism and pharmacokinetics of phenelzine: lack of evidence for acetylation pathway in humans. (1985) (37)
- Amphetamine and negative symptoms of schizophrenia (2005) (37)
- Electrocardiographic changes with nortriptyline and 10-hydroxynortriptyline in elderly depressed outpatients. (1988) (36)
- Prolactin response to fenfluramine administration in patients with unipolar and bipolar depression and healthy controls (2003) (36)
- Cannabinoid receptor 1 signaling in embryo neurodevelopment. (2012) (36)
- Preliminary data on the relationship between nortriptyline plasma level and response in depressed children. (1986) (36)
- Fenfluramine challenge test as a predictor of outcome in major depression. (1993) (35)
- ANTIPSYCHOTIC-INDUCED VACUOUS CHEWING MOVEMENTS AND EXTRAPYRAMIDAL SIDE-EFFECTS ARE HIGHLY HERITABLE IN MICE (2010) (35)
- Clozapine: Plasma levels and prolactin response (2004) (34)
- Plasma imipramine concentrations in patients receiving concomitant fluphenazine decanoate. (1982) (34)
- Determination of plasma ziprasidone using liquid chromatography with fluorescence detection. (2004) (34)
- A sensitive GLC method for the determination of imipramine and desmethylimipramine using a nitrogen detector. (1975) (34)
- Antidepressant drugs with varying pharmacological profiles alter rat pineal beta adrenergic-mediated function. (1984) (34)
- Clinical predictors of response to antidepressants in elderly patients (1987) (33)
- The comparative toxicity of cocaine and its metabolites in conscious rats. (1999) (33)
- Dexamethasone suppression test and plasma dexamethasone levels in bulimia. (1987) (33)
- Low plasma eicosapentaenoic acid levels are associated with elevated trait aggression and impulsivity in major depressive disorder with a history of comorbid substance use disorder. (2014) (32)
- Monoamine Oxidase Inhibitors as Antidepressants (1980) (32)
- Innate difference in the endocannabinoid signaling and its modulation by alcohol consumption in alcohol‐preferring sP rats (2012) (32)
- Effects of electroconvulsive therapy on plasma vasopressin and oxytocin (1998) (32)
- Haloperidol Half-life After Chronic Dosing (2004) (32)
- Sex-specific neurobiological actions of prophylactic (R,S)-ketamine, (2R,6R)-hydroxynorketamine, and (2S,6S)-hydroxynorketamine (2020) (31)
- A sensitive method for the determination of amitriptyline and nortriptyline in human plasma. (1976) (31)
- Fluphenazine plasma levels, dosage, efficacy, and side effects. (1995) (31)
- Age effects on cortisol levels in depressed patients with and without comorbid post-traumatic stress disorder, and healthy volunteers. (2004) (30)
- Timing of neuroendocrine responses and effect of m-CPP and fenfluramine plasma levels in OCD (1993) (30)
- High-dose treatment with haloperidol: the effect of dose reduction. (2000) (29)
- A cannabinoid analogue of Delta9-tetrahydrocannabinol disrupts neural development in chick. (2008) (29)
- Acute tryptophan depletion attenuates the prolactin response to d-fenfluramine challenge in healthy human subjects (1998) (29)
- Dose and plasma levels of nortriptyline and chlorpromazine in delusionally depressed adolescents and of nortriptyline in nondelusionally depressed adolescents. (1985) (29)
- Assessment of Relationship of Ketamine Dose With Magnetic Resonance Spectroscopy of Glx and GABA Responses in Adults With Major Depression (2020) (29)
- Hostility is associated with a heightened prolactin response to meta-chlorophenylpiperazine in abstinent cocaine addicts (1998) (27)
- Cortisol levels, immune status, and mood in homosexual men with and without HIV infection. (1993) (27)
- Determination of mianserin and metabolites in plasma by liquid chromatography with electrochemical detection. (1982) (27)
- Preliminary findings on the interactive effects of IV ethanol and IV nicotine on human behavior and cognition: a laboratory study. (2012) (27)
- CORRELATION OF TYPE A BEHAVIOUR WITH ADRENERGIC RECEPTOR DENSITY: IMPLICATIONS FOR CORONARY ARTERY DISEASE PATHOGENESIS (1987) (27)
- Simultaneous determination of amitriptyline, nortriptyline and their respective isomeric 10-hydroxy metabolites in plasma by liquid chromatography. (1982) (27)
- Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers. (2013) (26)
- Steady state pharmacokinetics of nortriptyline in the frail elderly. (1989) (26)
- Determination of trimipramine and metabolites in plasma by liquid chromatography with electrochemical detection. (1984) (26)
- 5-HT2a/2c receptor blockade by amesergide fully attenuates prolactin response tod-fenfluramine challenge in physically healthy human subjects (1996) (26)
- Higher cortisol levels in spring and fall in patients with major depression (2005) (26)
- Lithium kinetics in man: effect of variation in dosage pattern (1973) (25)
- Plasma homovanillic acid in neuroleptic responsive and nonresponsive schizophrenics (1993) (24)
- Hypothalamic - Pituitary - Adrenocortical Function in Geriatric Depression: Diagnostic and Treatment implications (1984) (24)
- Acute cardiovascular effects of tranylcypromine: correlation with plasma drug, metabolite, norepinephrine, and MHPG levels. (1991) (24)
- Fluphenazine blood levels and clinical response. (1982) (23)
- The iodine requirement and influence of iodine intake on iodine metabolism and thyroid function in the adult beagle. (1975) (23)
- Effect of plasma from patients containing bupropion and its metabolites on the uptake of norepinephrine (1986) (23)
- Effects of haloperidol and reduced haloperidol on binding to σ sites (1994) (23)
- Elevated plasma tricyclic levels with therapeutic doses of imipramine. (1984) (23)
- Child and Adolescent Nortriptyline Single Dose Pharmacokinetic Parameters: Final Report (1987) (22)
- Amitriptyline and hydroxylated metabolite plasma levels in depressed outpatients. (1985) (22)
- Beta-endorphin--induced changes in schizophrenic and depressed patients. (1977) (22)
- The usefulness of DST in predicting response to antidepressants: a placebo-controlled study. (1986) (22)
- Relationship between plasma antidepressant levels and clinical outcome for inpatients receiving imipramine. (1982) (22)
- Single-dose pharmacokinetics of fluphenazine after fluphenazine decanoate administration. (1990) (21)
- Ketamine metabolite pilot study in a suicidal depression trial. (2019) (21)
- A controlled sevn year study of endocrine and other indices in drug treated chronic schizophrenics. (1968) (21)
- Plasma Levels of Catecholamines and Dihydroxyphenylglycol during Antidepressant Drug Treatment (1983) (21)
- Serial ECG measurements at controlled plasma levels of nortriptyline in depressed children. (1985) (21)
- Relationship of platelet MAO activity to characteristics of major depressive illness (1986) (20)
- Pregnancy alters the hemodynamic responses to cocaine in the rat. (1992) (20)
- Abnormal behavioral responses to fenfluramine in patients with affective and personality disorders Correlation with increased serotonergic responsivity (1994) (20)
- Clozapine plasma level monitoring: Current status (1996) (20)
- Baseline and 2- to 3-year follow-up characteristics of placebo-washout responders from the nortriptyline study of depressed 6- to 12-year-olds. (1992) (20)
- Effects of fenfluramine on plasma HVA in OCD (1992) (20)
- A placebo-controlled comparison of the effect of nortriptyline and phenelzine on orthostatic hypotension in elderly depressed patients. (1987) (19)
- Double-blind, placebo-controlled study of nortriptyline in depressed children using a "fixed plasma level" design. (1989) (19)
- Change in plasma prolactin and clinical response to haloperidol in schizophrenia and schizoaffective disorder (1998) (18)
- Lipid correlates of antidepressant response to omega-3 polyunsaturated fatty acid supplementation: A pilot study. (2017) (18)
- The 24-hour lithium level as a prognosticator of dosage requirements: a 2-year follow-up study. (1976) (18)
- Identification of drug-related cognitive impairment in older individuals. Challenge studies with diphenhydramine. (1997) (18)
- Placental transfer of (3H)-GM1 and its distribution to maternal and fetal tissues of the rat. (1993) (18)
- The dose-response characteristics of rat oral dyskinesias with chronic haloperidol or clozapine administration (2005) (18)
- Effect of varying haloperidol plasma levels on negative symptoms in schizophrenia and schizoaffective disorder. (1996) (17)
- The lithium test dose prediction method in aggressive children. (1995) (17)
- Combined catecholamine and indoleamine depletion following response to ECT (2010) (17)
- The apolipoprotein E ɛ4 allele and memory performance in HIV-1 seropositive subjects: differences at baseline but not after acute oral lorazepam challenge (2008) (17)
- Relative safety of single versus divided dose imipramine in adolescent major depression. (1987) (17)
- Imipramine and its metabolites: relationship to cerebral catecholamines in rats in vivo. (1984) (17)
- Haloperidol blood levels and effects in schizophrenia and schizoaffective disorder: a progress report. (1990) (17)
- Brain serotonin transporter binding, plasma arachidonic acid and depression severity: A positron emission tomography study of major depression. (2019) (17)
- Fluphenazine decanoate dose and severity of depression in patients with post-psychotic depression (1988) (16)
- Clinical and plasma level characteristics of intramuscular and oral loxapine (1978) (16)
- The effect of imipramine treatment on brain serotonin receptors and β-adrenoceptors and on pineal β-adrenergic function in adult and aged rats (1986) (16)
- Plasma tricyclic drug levels in amitriptyline-treated depressed patients (1979) (16)
- Direct radioimmunoassay procedure for plasma dexamethasone with a sensitivity at the picogram level. (1989) (16)
- Cardiovascular effects of doxepin in cardiac patients with ventricular arrhythmias (1987) (16)
- Response of the melatonin cycle to phototherapy for Seasonal Affective Disorder (2005) (16)
- Prospective study of scheduled withdrawal from nortriptyline in children and adolescents. (1987) (16)
- Naloxone, tardive dyskinesia, and endogenous beta-endorphin (1982) (16)
- Conversion of lipotropic peptides by purified cathepsin D of human pituitary: Release of γ-endorphin by cleavage of the Leu77-PHE78 bond (1978) (16)
- Cortisol Stress Response and in Vivo PET Imaging of Human Brain Serotonin 1A Receptor Binding (2019) (16)
- The treatment of affective disorders in the elderly. (1983) (15)
- Serial dexamethasone suppression tests and plasma dexamethasone levels. Effects of clinical response to electroconvulsive therapy in major depression. (1991) (15)
- Butaperazine pharmacokinetics. Effect of dosage regimen on steady state blood levels. (1975) (14)
- Concomitant imipramine and methylphenidate administration: a case report. (1973) (14)
- Pharmacokinetics of desipramine in Asian and Caucasian volunteers. (1989) (14)
- Modification of ligand binding to membranes by a soluble acceptor Alpha-1-acid glycoprotein attenuates 3H-Imipramine binding to cerebral membranes (1986) (14)
- 2-Hydroxydesipramine and desipramine plasma levels and electrocardiographic effects in depressed younger adults. (1991) (14)
- Relationships Between Inflammatory Markers and Suicide Risk Status in Major Depression (2020) (14)
- Prediction of response to nortriptyline and phenelzine by platelet MAO activity. (1987) (14)
- Serotonin in violent patients with schizophrenia (1995) (14)
- The relationship between blood levels of different forms of butaperazine and clinical response. (1973) (14)
- The Effect of Mifepristone (RU 486) on Plasma Cortisol in Alzheimer’s Disease (2006) (14)
- Effect of fluoxetine on plasma desipramine and 2-hydroxydesipramine (1992) (13)
- The Number of Previous Depressive Episodes Is Positively Associated with Cortisol Response to Fenfluramine Administration (2004) (13)
- Down regulation of β-receptors by bupropion and its major metabolite in mouse brain (1986) (13)
- Neuroleptic plasma level may predict response in patients who meet a criterion for improvement. (1988) (13)
- Inhibition of 3H-imipramine binding by plasma from depressed and normal subjects (1986) (13)
- Prenatal ganglioside GM1 treatment protects ethanol‐induced sleep time in rats exposed to ethanol in utero during gestation days 7 and 8 (1991) (13)
- Lithium and haloperidol (1986) (13)
- Association of X-box binding protein 1 ( XBP1) genotype with morning cortisol and 1-year clinical course after a major depressive episode. (2009) (13)
- A highly sensitive and specific radioimmunoassay for quantitation of plasma fluphenazine. (1988) (13)
- Tyramine Sulfate excretion may be a better predictor of antidepressant response than Monoamine Oxidase activity (1988) (12)
- Beta-endorphine-induced changes in schizophrenic and depressed patients N.S. Kline, C.H. Li, H.E. Lehmann, A. Lajtha, E. Laski and T. Cooper, Arch. gen. Psychiat., 34 (1977) 1111–1113 (1979) (12)
- Low dose oral haloperidol and blood levels in Alzheimer's disease: a preliminary study. (1992) (12)
- Serum prolactin levels in homosexual and bisexual men with HIV infection. (1992) (12)
- Plasma levels of nortriptyline and 10-hydroxynortriptyline and treatment-related electrocardiographic changes in the elderly depressed. (1989) (12)
- Modified dexamethasone suppression-corticotropin-releasing hormone stimulation test: A pilot study of young healthy volunteers and implications for alcoholism research in adolescents and young adults (2006) (12)
- Determination of phenelzine in human plasma with gas chromatography-mass spectrometry using an isotope labeled internal standard. (1980) (12)
- Plasma dexamethasone and cortisol levels in depressed outpatients. (1989) (12)
- Multidose Risperidone Treatment Evaluated in a Rodent Model of Tardive Dyskinesia (2006) (12)
- Electrocardiographic effects of nortriptyline, phenelzine, and placebo under optimal treatment conditions. (1987) (11)
- Pretreatment plasma HVA and haloperidol response in acute mania. (2000) (11)
- Relationship of hydroxynortriptyline to nortriptyline concentration and creatinine clearance in depressed elderly outpatients. (1990) (11)
- Positron emission tomography study of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without comorbid lifetime alcohol dependence (2007) (11)
- Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [11C]-(+)-PHNO (2019) (11)
- Thyroid indices in chronic schizophrenia. 3. (1966) (10)
- Usefulness of plasma haloperidol levels for monitoring clinical efficacy and side effects in Alzheimer patients with psychosis and behavioral dyscontrol. (2003) (10)
- Cardiovascular effects of phenelzine and amitriptyline in depressed outpatients. (1982) (10)
- Postmortem blood and tissue levels of loxapine and its metabolites. (1981) (10)
- Preliminary report of a longitudinal study of the effects of lithium on iodine metabolism. (1969) (10)
- Concurrent lithium administration results in higher haloperidol levels in brain and plasma of guinea pigs (1987) (10)
- Dose-related differences in the distribution of cocaine in the maternal-fetoplacental compartments in rats. (2000) (10)
- The nephrotoxicity of Isotropis forrestii in sheep. (1986) (9)
- The recency ratio is associated with reduced CSF glutamate in late-life depression (2017) (9)
- Dual pharmacological inhibitor of endocannabinoid degrading enzymes reduces depressive-like behavior in female rats. (2020) (9)
- Saliva and plasma desipramine levels in Asian and Caucasian volunteers. (1991) (9)
- Measurement of lithium concentrations in human tears. (1982) (8)
- Nortriptyline Pharmacokinetic Parameters in Depressed Children and Adolescents: Preliminary Data (1984) (8)
- The effect of three butyrophenones on serum cholesterol levels. (1966) (8)
- Placebo washout in trials of antipsychotic drugs. (1996) (8)
- Tyramine Conjugation Deficit in Type Headache, and Depression Migraine, Tension- (1995) (8)
- The disposition of cocaethylene in rat maternal, placental, and fetal compartments. (1999) (8)
- Determination of 3,4-dihydroxyphenyl glycol in plasma by gas chromatography-mass spectrometry and high-performance liquid chromatography methods. (1996) (8)
- Bioequivalency of generic and brand‐named chlorpromazine (1974) (8)
- Monitoring Lithium Dose Levels: Estimation of Lithium in Blood and Other Body Fluids (1981) (8)
- Lithium accumulation in the neurointermediate lobe of rat pituitary exceeds that in other endocrine glands (1993) (8)
- Pharmacokinetics of desipramine in Caucasian and Asian volunteers. (1986) (8)
- Prediction of Individual Dosage of Nortriptyline in Depressed Elderly Outpatients (1987) (7)
- Pregnancy decreases the threshold for cocaine-induced convulsions in the rat. (1993) (7)
- Role of gender in the toxicity of norcocaine. (1999) (7)
- Protection of patients on MAOI's against hypertensive crises. (1981) (7)
- Prevention of lithium nephrotoxicity in a novel one-hour model in rats (1998) (7)
- Rapid and sensitive determination of nalmefene in human plasma by gas chromatography-mass spectrometry. (2002) (7)
- Persistent psychosis after reduction in pre- and post-synaptic dopaminergic function (2005) (7)
- Serial monitoring and achievement of steady state nortriptyline plasma levels in depressed children and adolescents: preliminary data. (1985) (7)
- Sensitive and simple gas chromatographic-mass spectrometric determination for amphetamine in microdialysate and ultrafiltrate samples. (2004) (6)
- Pregnancy enhances cocaine-induced stimulation of uterine contractions in the chronically instrumented rat. (1996) (6)
- The disposition of benzoylecgonine in maternal and fetal rats. (2001) (6)
- Further studies on the effect of butyrophenones on cholesterol synthesis in humans. (1967) (6)
- Omega-3 Polyunsaturated Fatty Acid Status in Major Depression with Comorbid Anxiety Disorders (2014) (6)
- Neuroendocrine sensitivity in obsessive-compulsive disorder (1989) (6)
- Neurohormonal and behavioral response to methylphenidate in cocaine abstinence (1996) (6)
- Monitoring of clozapine blood levels in the real world. (1996) (6)
- Serum dopamine-beta-hydroxylase activity in depression and anxiety. (1984) (6)
- An Improved Method for the Determination of Reserpine in Plasma Using Liquid Chromatography with Fluorescence Detection (1983) (6)
- Iodoamino acid distribution in the serum of schizophrenic patients receiving perphenazine. (1963) (6)
- 5-HT3 receptor antagonism by ondansetron does not attenuate prolactin response to d-fenfluramine challenge in healthy human subjects. (1996) (5)
- Effect of extended depot fluphenazine treatment and withdrawal on social and other behaviors ofCebus apella monkeys (2005) (5)
- Neuroleptic drug monitoring and radioreceptor assays. (1985) (5)
- Child and adolescent nortriptyline single dose kinetics predict steady state plasma levels and suggested dose: preliminary data. (1985) (5)
- Serotonergic responses in depressed patients with or without a history of alcohol use disorders and healthy controls (2008) (5)
- Hormonal responses to meta-chlorophenylpiperazine (m-CPP) are undiminished by acute m-CPP pretreatment (1996) (5)
- Long-term intravenous perinatal cocaine exposure on the mortality of rat offspring. (2000) (5)
- A879 THE MATERNAL TO FETAL TRANSFER OF BENZOYLECGONINE (1997) (5)
- elta-9-Tetrahydrocannabinol Effects in chizophrenia : Implications for Cognition , sychosis , and Addiction eepak (2005) (5)
- Lithium and thyroid function. (1969) (5)
- Different pattern of association of beta-endorphin and cortisol responses to dextroamphetamine in postmenopausal women and young men (1985) (5)
- Prediction of steady state plasma and saliva levels of desmethylimipramine using a single dose, single time point procedure (2004) (5)
- Antidepressants in the treatment of post-psychotic depression in schizophrenia: drug interactions and other considerations. (1988) (5)
- Monitoring lithium dose levels: estimation of lithium in blood and other body fluids. (1981) (5)
- Phenelzine measurement in human plasma: a sensitive GLC-ECD procedure. (1978) (5)
- Effects of imipramine and phenelzine on plasma PEA levels (1988) (5)
- Magnesium and bupivacaine-induced convulsions in awake pregnant rats. (2005) (4)
- Lithium, controversies and unresolved issues : proceedings of the International Lithium Conference, New York, June 5-9, 1978 (1979) (4)
- Haloperidol Blood Levels in Acute Mania With Psychosis (2001) (4)
- Lack of weight gain under desipramine (1987) (4)
- Effects of loxapine on the sleep of chronic schizophrenics (1979) (4)
- Effects of haloperidol and reduced haloperidol on binding to sigma sites. (1994) (4)
- Neuroleptic treatment, symptoms of schizophrenia, and plasma homovanillic acid concentrations revisited. (1992) (4)
- Amitriptyline protects patients on MAOIs from tyramine reactions. (1982) (4)
- Plasma/blood level monitoring techniques in psychiatry. (1975) (4)
- Effects of Rapastinel (Formerly GLYX-13) on Serum Brain-Derived Neurotrophic Factor in Obsessive-Compulsive Disorder. (2018) (4)
- Plasma drug level and clinical response. (1992) (3)
- Antidepressant response to electroconvulsive therapy is sustained after catecholamine depletion (2009) (3)
- The efficacy of melatonin in the treatment of jet lag (1998) (3)
- The drug-free period: A methodological issue (1990) (3)
- GLC/MS assay for loxapine in human biofluids and tissues with deuterium labeled analog as an internal standard. (1982) (3)
- Lithium distribution in experimental inflammation of brain and spinal cord (1996) (3)
- Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate. (1988) (3)
- TWO-YEAR FOLLOW-UP STUDY OF PROTEIN-BOUND IODINE ELEVATION IN PATIENTS RECEIVING PERPHENAZINE. (1965) (3)
- The effect of imipramine treatment on brain serotonin receptors and beta-adrenoceptors and on pineal beta-adrenergic function in adult and aged rats. (1986) (3)
- Will amitriptyline prevent the ???cheese??? reaction of monoamine oxidase inhibitors? (1983) (3)
- Determination of amoxapine and metabolites in plasma by liquid chromatography with electrochemical detection. (1985) (2)
- Serotonin depletion induced by reserpine is attenuated by prophylactic administration of lithium. (1985) (2)
- VACUUM MANIFOLD FOR USE IN ERYTHROCYTE UPTAKE OF T3 TECHNIC. (1965) (2)
- Hydroxocobalamin and SodIum Thiosulfate Interfere Negatively wIth Measurement of Creatine Kinase ActIvIty (2004) (2)
- Gas—Liquid Chromatography of Antidepressant, Antipsychotic, and Benzodiazepine Drugs in Plasma and Tissues (1988) (2)
- 5-HT3 receptor antagonism by ondansetron does not attenuate prolactin response tod-fenfluramine challenge in healthy human subjects (1996) (2)
- Post‐dexamethasone cortisol levels and computerized tomographic findings in manic patients (1993) (2)
- Sensitiveand SelectiveLiquid-Chromatographic Assayof Fluoxetineand Norfluoxetine in PlasmawithFluorescence Detectionafter PrecolumnDerivatization (1992) (2)
- Plasma homovanillic acid in psychotic depression (1993) (2)
- Influence of body size on lithium levels in rats (1997) (2)
- The implications of left ventricular performance for tricyclic antidepressant drug treatment (1983) (2)
- 2‐Hydroxydesipramine and desipramine plasma levels: how are they related to antidepressant response? (1996) (2)
- Influence of Strain, Sex and Age on Nephrotoxicity of Lithium in a One-Hour Model in Rats (2001) (2)
- 10-Hydroxynortriptyline and treatment effects in elderly depressed patients. (1989) (2)
- Tricyclic Antidepressant Drug and Metabolite Levels in Chronic Renal Failure (1986) (2)
- Brain regional [3H]flunitrazepam binding in rats chronically treated with bupropion or B.W.306U (1986) (1)
- MUSCARINIC SUPERSENSITIVITY IN ALZHEIMER'S DISEASE–POS.S I BLE DIAGNOSTIC AND THERAPEUTIC IMPLICATIONS (1988) (1)
- Second International Symposium on the Economic and Social Costs of Substance Abuse (1997) (1)
- Alcohol reduces GM1 ganglioside content in the serum of inbred mouse strains. (2004) (1)
- Lithium dosing guide. (1982) (1)
- Isolation and identification of the glucuronide conjugate of 2-hydroxydesipramine by preparative liquid chromatography. (1988) (1)
- Contribution to the mode of action of lithium on iodine metabolism. (1970) (1)
- DISPOSITION OF COCAETHYLENE IN THE MATERNAL-PLACENTAL AND FETAL UNIT IN THE AWAKE RAT (1998) (1)
- Maternal Cerebrospinal Fluid Glutamate in Response to Variable Foraging Demand: Relationship to Cerebrospinal Fluid Serotonin Metabolites in Grown Offspring (2018) (1)
- Plasma-serum differences in the assessment of tricyclic antidepressant blood levels. (1987) (1)
- THYROXINE SERUM PROTEIN COMPLEXES IN SCHIZOPHRENIA. (1965) (1)
- Analytical Aspects of the Pharmacokinetics of Psychotropic Drugs (1982) (1)
- Effects of lithium on seizure susceptibility in alcoholized and non-alcoholized rats. (1977) (1)
- Pregnancy Enhances Acute Intoxication By Cocaine In The Rat (1989) (1)
- Usefulness of single plasma desipramine levels. (1983) (1)
- Plasma Levels of Antidepressants and Therapeutic Effects1 (1981) (1)
- Baseline Plasma GABA: Its Relationship to the Adverse Effects of Acute Lorazepam Administration on Cognition in the Elderly (2004) (1)
- REDUCED SEROTONIN RESPONSIVITY IN DEPRESSION. AUTHORS' REPLY (1997) (0)
- placeboof depressive symptoms to nortriptyline, phenelzine and (2011) (0)
- Dr. Bilder and Colleagues Reply (2002) (0)
- Contents Vol. 89, 2001 (2001) (0)
- Comment on “does oxytocin release correlate with ECT's efficacy?” (1994) (0)
- 427. Reduced heart rate response to nortriptyline in females with unipolar depression (1996) (0)
- THYROID INDICES IN CHRONIC SCHIZOPHRENIA: III (1966) (0)
- Decreased Tyramine Conjugation in Melancholia: A Trait Marker (1988) (0)
- Effects of fenfluramine on plasma homovanillic acid in healthy subjects (2005) (0)
- The effect of nortriptyline on verbal recall (1995) (0)
- Disposition of Cocaine in Pre-and-Postnatally Cocaine Exposed Rat Offspring: [2002][A-1057] (2002) (0)
- S65. MATERNAL CORTISOL DURING PREGNANCY, SCHIZOPHRENIA, AND FETAL GROWTH (2019) (0)
- PREGNANCY ALTERS THE PHARMACODYNAMICS OF COCAINE IN RATS (1991) (0)
- SECTION V: THYROID FUNCTION (1968) (0)
- Inconsistency in Developing Neurobehavioral Toxicity of Cocaine in the Newborn Rat: I. Kinetic Considerations (1994) (0)
- Corrigendum to"Ketamine metabolite pilot study in a suicidal depression trial" [J Psychiatr Res 117 (2019) 129-134. doi: 10.1016/j.jpsychires.2019.08.005. Epub 2019 Aug 9]. (2019) (0)
- Pharmacodynamics of Cocaine and Uterine Activity in the Rat (1994) (0)
- Antidepressantsin the Treatment of Post-PsychoticDepressionin Schizophrenia:Drug Interactionsand other Considerations (2004) (0)
- Factors Affecting the Delay of Antidepressant Responders to Nortriptyline and Phenelzine (1989) (0)
- The effect of phenothiazines on cerebrospinal fluid. (1966) (0)
- Reply from Dr. Stern and associates (1992) (0)
- The Effect Of MgSO4 On Bupivacaine-Induced Convulsions In Awake Rats. A16 (2000) (0)
- PLACENTAL TRANSFER AND DISPOSTION OF COCAINE IN THE PREGNANT SHEEP (1992) (0)
- Short communication Does clozapine decrease smoking (2005) (0)
- Ovarian hormones mediate the prophylactic efficacy of (R,S)-ketamine and (2R,6R)-hydroxynorketamine in female mice (2019) (0)
- Studies on the mechanism of lithium action: preliminary report. (1975) (0)
- Production of Metabolites of L-Deprenyl and pFluoro-L-Deprenyl in Rat Brain After Central Administration (1997) (0)
- PS278. Association of testosterone levels and future suicide attempts in women with bipolar disorder: A prospective study (2016) (0)
- therapy in patients with major depression Enhanced serotonergic responsivity following electroconvulsive (2011) (0)
- Salivary lithiolith? (1983) (0)
- Dr. Volavka and Colleagues Reply (2003) (0)
- Post-dexamethasone cortisol levels and third ventricular enlargement in manic patients (1989) (0)
- Longitudinal studies on depressed elderly (1989) (0)
- Behavioral and Neuroendocrine Responses to Oral m-Chlorophenylpiperazine and Fenfluramine in Patients and Healthy Volunteers (2016) (0)
- Serum concentrations of secondary amine tricyclic antidepressants may be lower than those measured from plasma. (1987) (0)
- PLACENTAL TRANSFER AND DISTRIBUTION OF GANGLIOSIDE GM1 IN PREGNANT RATS AND THEIR FETUSES (1992) (0)
- Comparative effectiveness of antipsychotic drugs. Authors' reply (2003) (0)
- Lack of effect of M-CPP on noradrenergic and dopaminergic systems in women (1993) (0)
- Acute HVA and prolactin response to fluphenazine challenge in patients with psychosis and/or stimulant abuse (1989) (0)
- Relationship between plasma desipramine levels and clinical outcome for RDC major depressive inpatients (2004) (0)
- SECTION VIII: DISCUSSION (1968) (0)
- Species-Related Differences in Bupivacaine Metabolites during Pregnancy: [2002][A-1038] (2002) (0)
- 102-2 ECT and altered serotonergic responsivity (1997) (0)
- Time course of subjective side effects on desipramine (1989) (0)
- A929 AGE-RELATED COCAINE UPTAKE IN RATS (1990) (0)
- Pertussis vaccine and pertussis toxin increase lithium levels in rats: Possible role of g-proteins (2000) (0)
- Perphenazine and serum protein bound iodine. (1968) (0)
- Reply (2007) (0)
- Long-term Ingestion of Cocaine Decreases Its Toxic Threshold (1994) (0)
- Randomized Controlled Trial Relapse Following Electroconvulsive Therapy : A Continuation Pharmacotherapy in the Prevention of Correction (2001) (0)
- MATERNAL AND FETAL SUPPRESSION OF SERUM METHIONINE AFTER PROLONGED EXPOSURE TO NITROUS OXIDE (1988) (0)
- Subject Index Vol. 89, 2001 (2001) (0)
- A Study of the Pericycle in the Caprifoliaceae (1939) (0)
- Attenuation by electroshock treatment of the haloperidol-induced rise in the binding of 3H-imipramine to rat brain membranes (2004) (0)
- Room I, 10/16/2000 9: 00 AM - 11: 00 AM (PS) Neurotoxicity of Benzoylecgonine A-1058 (2000) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Thomas Β Cooper,?
Thomas Β Cooper, is affiliated with the following schools: